Article 10 Mar 2021 Biolojic Design Ltd. Research Collaboration And License Agreement With Eli Lilly United States IP
Article 07 May 2020 Orgenesis Announces Agreement To Acquire Assets Of Tamir Biotechnology, Inc. Including Broad Spectrum Antiviral Platform United States Healthcare
Article 02 May 2020 Tyto Care Secures Financing From Pearl Cohen Clients To Provide Remote Medical Exams United States Coronavirus
Article 28 Feb 2020 Orgenesis Inc. (NASDAQ: ORGS) Announces Agreement For The Sale Of Masthercell Global For $315 Million United States Commercial
Article 31 Jul 2019 Humanigen Secures Exclusive Worldwide License For The Prevention Of GvHD Through GM-CSF Neutralization From The University Of Zurich United States IP
Article 22 May 2019 Orgenesis Strikes Deal With Columbia University To Develop Cellular Vaccination Product Platform United States Healthcare